ADIPOQ and cardiovascular disorder: Adiponectin has been reported as a predictor of all-cause and cardiovascular mortality in individuals aged 50 to 75 in whom cardiovascular diseases were prevalent43 and causally associated with cardiovascular mortality in T2D patients44.